Results of chemotherapy in 30 AIDS patients with symptomatic pulmonary Kaposi's sarcoma.

J L Cadranel, S Kammoun, S Chevret, A Parrot, M Denis, C Winter, M F Carette, W Rozenbaum, G M Akoun, C M Mayaud

Services de Pneumologie et Réanimation Respiratoire, Hôpital Tenon, Paris, France.

BACKGROUND--The aim of this study was to report the effects of a three-drug chemotherapy regimen in patients with symptomatic AIDS-related pulmonary Kaposi's sarcoma and to analyse prognostic factors for survival. METHODS--Thirty consecutive HIV seropositive patients with respiratory symptoms and proven pulmonary Kaposi's sarcoma were treated with the same therapeutic regimen comprising adriamycin (30 mg/m2), bleomycin (10 mg/m2), and vincristine (2 mg) administered intravenously once every four weeks. RESULTS--Two patients died during the first course of chemotherapy. In the other 28 cases dyspnoea improved and Pao2 rose despite minimal (n = 17) or no (n = 11) improvement in the chest radiographic appearance. The median survival from the beginning of chemotherapy was 6.5 months. Poor prognostic factors for survival were: (1) absence of cutaneous Kaposi's sarcoma; (2) previous opportunistic infection; (3) CD4 cell count < 100/microliters; (4) leucocytes < 3500/microliters; (5) haemoglobin < 10 g/dl; and (6) absence of radiological response. Of the 28 patients 24 experienced at least one episode of neutropenia which was associated with bacterial infection in 16 cases. CONCLUSIONS--Chemotherapy may improve respiratory impairment in patients with extensive pulmonary Kaposi's sarcoma but the outcome remains poor. The efficacy of chemotherapy may be limited by neutropenia.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Cadranel, J., Mayaud, C. (2007). Lung cancer in HIV infected patients. Thorax 62: 557-557 [Full Text]  
• Masur, H. (2006). Management of Patients with HIV in the Intensive Care Unit.. Proc Am Thorac Soc 3: 96-102 [Abstract] [Full Text]  
• Holkova, B., Takeshita, K., Cheng, D. M., Volm, M., Wasserheit, C., Demopoulos, R., Chanan-Khan, A. (2001). Effect of Highly Active Antiretroviral Therapy on Survival in Patients With AIDS-Associated Pulmonary Kaposi's Sarcoma Treated With Chemotherapy. JCO 19: 3848-3851 [Abstract] [Full Text]  
• Aboulafia, D. M. (2000). The Epidemiologic, Pathologic, and Clinical Features of AIDS-Associated Pulmonary Kaposi’s Sarcoma. Chest 117: 1128-1145 [Abstract] [Full Text]  
• Boswell, S. L., van Gorder, M. (1997). Case 27-1997- A 38-Year-Old Man with the Acquired Immunodeficiency Syndrome and Cavitary Pulmonary Lesions. NEJM 337: 619-627 [Full Text]